GlassScriptPhysician profile
Sandy Wong
NPI 1811562580
$5,322.91
in general payments reported to CMS, 2019-2025
10 companies · $4,138 in 2025
The $4,138 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $151 · 2023: $23.95 · 2024: $1,010 · 2025: $4,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,750 · Food and Beverage: $2,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,749.78 |
| Food and Beverage | $2,421.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $2,563.95 | 2024-2025 | Radius Xr, Travoprost Intraocular Implant - Idose, Istent Infinite |
| Johnson & Johnson Surgical Vision, INC. | $1,226.07 | 2024-2025 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Alcon Vision LLC | $953.33 | 2023-2025 | Clareon, Acrysof Iq Panoptix Uv Iol, Acrysof Iq Vivity |
| Rxsight INC | $147.47 | 2025 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| E.R. Squibb & Sons, L.L.C. | $116.24 | 2022 | |
| Bausch & Lomb Americas INC. | $112.13 | 2024 | Ic-8 Apthera Iol, Envista Mx60 Iol |
| Biotissue Holdings INC. | $106.06 | 2024-2025 | |
| Emd Serono, INC. | $34.90 | 2022 | |
| Oyster Point Pharma, INC. | $31.48 | 2024 | Tyrvaya |
| Abbvie INC. | $31.28 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.